BioLineRx Ltd. Reports Second Quarter 2012 Results

August 15, 2012 |

1 min read

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended June 30, 2012.

Earnings Asia

MORE ON THIS TOPIC

Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.

Obesity

Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study

February 10, 2026

·

1 min read

·

Tristan Manalac

Focus on the path, Businessman running on his own track

Earnings

AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details

February 10, 2026

·

2 min read

·

Tristan Manalac

There is one person missing to complete the team

Recruiting

Facing Talent Crunch, Radiopharma Field Casts a Wide Net

February 10, 2026

·

4 min read

·

Nick Paul Taylor

Creativity and new ideas in business. Art collage.

Mergers & acquisitions

Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune

February 9, 2026

·

2 min read

·

Dan Samorodnitsky